# Short Term Comparative Assessment of MTA and Biodentine in Complete Pulpotomy for Symptomatic Irreversible Pulpitis

> **NCT07483788** · NA · RECRUITING · sponsor: **Dow University of Health Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Symptomatic Irreversible Pulpitis (SIP)

## Interventions

- **OTHER:** Biodentine pulpotomy

## Key facts

- **NCT ID:** NCT07483788
- **Lead sponsor:** Dow University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-02
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-07-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07483788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07483788, "Short Term Comparative Assessment of MTA and Biodentine in Complete Pulpotomy for Symptomatic Irreversible Pulpitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07483788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*